Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, March 16, 2023
[ Thu, Mar 16th 2023
] - WOPRAI
[ Thu, Mar 16th 2023
] - WOPRAI
[ Thu, Mar 16th 2023
] - WOPRAI
[ Thu, Mar 16th 2023
] - WOPRAI
[ Thu, Mar 16th 2023
] - WOPRAI
[ Thu, Mar 16th 2023
] - WOPRAI
[ Thu, Mar 16th 2023
] - WOPRAI
[ Thu, Mar 16th 2023
] - WOPRAI
[ Thu, Mar 16th 2023
] - WOPRAI
[ Thu, Mar 16th 2023
] - WOPRAI
[ Thu, Mar 16th 2023
] - WOPRAI
[ Thu, Mar 16th 2023
] - WOPRAI
[ Thu, Mar 16th 2023
] - WOPRAI
[ Thu, Mar 16th 2023
] - WOPRAI
Wed, March 15, 2023
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
[ Wed, Mar 15th 2023
] - WOPRAI
Bradley Canino Maintained (ZNTL) at Strong Buy with Decreased Target to $46 on, Mar 15th, 2023
Bradley Canino of Stifel, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Strong Buy with Decreased Target from $55 to $46 on, Mar 15th, 2023.
Bradley has made no other calls on ZNTL in the last 4 months.
There is 1 other peer that has a rating on ZNTL. Out of the 1 peers that are also analyzing ZNTL, 0 agree with Bradley's Rating of Hold.
This is the rating of the analyst that currently disagrees with Bradley
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $55 on, Thursday, March 2nd, 2023
